{"protocolSection":{"identificationModule":{"nctId":"NCT05508113","orgStudyIdInfo":{"id":"2022100"},"organization":{"fullName":"Jilin University","class":"OTHER"},"briefTitle":"Ozone Autohemotherapy for Ischemic Stroke Sleep Disorder","officialTitle":"Effects of Ozone Autohemotherapy on Patients With Post-ischemic Stroke Insomnia"},"statusModule":{"statusVerifiedDate":"2022-08","overallStatus":"NOT_YET_RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2022-08-26","type":"ESTIMATED"},"primaryCompletionDateStruct":{"date":"2022-12-31","type":"ESTIMATED"},"completionDateStruct":{"date":"2022-12-31","type":"ESTIMATED"},"studyFirstSubmitDate":"2022-08-17","studyFirstSubmitQcDate":"2022-08-17","studyFirstPostDateStruct":{"date":"2022-08-19","type":"ACTUAL"},"lastUpdateSubmitDate":"2022-08-18","lastUpdatePostDateStruct":{"date":"2022-08-22","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR_INVESTIGATOR","investigatorFullName":"Mengmeng Chen","investigatorTitle":"Principal Investigator","investigatorAffiliation":"Jilin University"},"leadSponsor":{"name":"Mengmeng Chen","class":"OTHER"}},"oversightModule":{"oversightHasDmc":true,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"The purpose of this study is to observe the efficacy and safety of ozonated autohemotherapy in patients of post-ischemic stroke insomnia and to explore its mechanism of action."},"conditionsModule":{"conditions":["Post-ischemic Stroke Insomnia"],"keywords":["Ischemic stroke","Insomnia","Ozone Autohemotherapy"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["NA"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"SUPPORTIVE_CARE","maskingInfo":{"masking":"DOUBLE","whoMasked":["PARTICIPANT","INVESTIGATOR"]}},"enrollmentInfo":{"count":60,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"Control","type":"NO_INTERVENTION","description":"No intervention was given to this group of patients"},{"label":"20-40ug/ml ozone","type":"EXPERIMENTAL","description":"ozone autohemotherapy","interventionNames":["Other: ozone autohemotherapy"]}],"interventions":[{"type":"OTHER","name":"ozone autohemotherapy","description":"After autologous blood is mixed with ozone in vitro, the blood is injected into the patient through intravenous infusion","armGroupLabels":["20-40ug/ml ozone"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Insomnia severity index","description":"The Insomnia Severity Index Scale (ISI) will be used, which scale ranges from 0 to 28, with higher scores representing more severe insomnia. Specifically, 0-5 points represent excellent sleep quality, 6-10 points mean good sleep quality, 11-15 points indicate average sleep quality, and 16-21 points represent poor sleep quality.","timeFrame":"2 weeks"},{"measure":"Pittsburgh Sleep Quality Index","description":"The Pittsburgh Sleep Quality Index Scale (PSQI) will be used, which scale ranges from 0 to 21, with higher scores representing poorer sleep quality. In detail, 0-7 points represent insomnia of no clinical significance, 8-14 points mean sub-clinical insomnia, 15-21 points indicate moderate clinical insomnia, and 22-28 points represent severe clinical insomnia.","timeFrame":"2 weeks"}],"secondaryOutcomes":[{"measure":"brain-derived neurotrophic factor (BDNF)","description":"Detection of BDNF in serum of patients using Elisa kit","timeFrame":"2 weeks"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* meet the diagnostic criteria for ischemic stroke; Insomnia quality index (ISI) score \\> 7 points\n\nExclusion Criteria:\n\n* acute ischemic stroke; associated with failure of important organs or malignant tumor; patients with worsening condition, new cerebral infarction or secondary cerebral hemorrhage; with comprehension or cognitive impairment, unable to fully understand the scale and unable to cooperate with treatment","healthyVolunteers":false,"sex":"ALL","stdAges":["CHILD","ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"centralContacts":[{"name":"Lijing Zhao, Doctor","role":"CONTACT","phone":"13756281155","email":"zhao_lj@jlu.edu.cn"}]},"referencesModule":{"references":[{"pmid":"29512465","type":"BACKGROUND","citation":"Sekerdag E, Solaroglu I, Gursoy-Ozdemir Y. Cell Death Mechanisms in Stroke and Novel Molecular and Cellular Treatment Options. Curr Neuropharmacol. 2018;16(9):1396-1415. doi: 10.2174/1570159X16666180302115544."},{"pmid":"33932964","type":"BACKGROUND","citation":"Masan J, Sramka M, Rabarova D. The possibilities of using the effects of ozone therapy in neurology. Neuro Endocrinol Lett. 2021 Mar;42(1):13-21."},{"pmid":"32618780","type":"BACKGROUND","citation":"Kadir K, Syam Y, Yusuf S, Zainuddin M. Ozone Therapy on Reduction of Bacterial Colonies and Acceleration of Diabetic Foot Ulcer Healing. Home Healthc Now. 2020 Jul/Aug;38(4):215-220. doi: 10.1097/NHH.0000000000000889."},{"pmid":"22796450","type":"BACKGROUND","citation":"Martinez-Sanchez G, Delgado-Roche L, Diaz-Batista A, Perez-Davison G, Re L. Effects of ozone therapy on haemostatic and oxidative stress index in coronary artery disease. Eur J Pharmacol. 2012 Sep 15;691(1-3):156-62. doi: 10.1016/j.ejphar.2012.07.010. Epub 2012 Jul 13."}]},"ipdSharingStatementModule":{"ipdSharing":"NO"}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"},{"id":"D000083242","term":"Ischemic Stroke"},{"id":"D000002544","term":"Cerebral Infarction"},{"id":"D000007319","term":"Sleep Initiation and Maintenance Disorders"},{"id":"D000007511","term":"Ischemia"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000010335","term":"Pathologic Processes"},{"id":"D000020520","term":"Brain Infarction"},{"id":"D000002545","term":"Brain Ischemia"},{"id":"D000007238","term":"Infarction"},{"id":"D000009336","term":"Necrosis"},{"id":"D000020919","term":"Sleep Disorders, Intrinsic"},{"id":"D000020920","term":"Dyssomnias"},{"id":"D000012893","term":"Sleep Wake Disorders"},{"id":"D000001523","term":"Mental Disorders"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M10233","name":"Ischemia","asFound":"Ischemic","relevance":"HIGH"},{"id":"M2401","name":"Ischemic Stroke","asFound":"Ischemic Stroke","relevance":"HIGH"},{"id":"M21932","name":"Parasomnias","relevance":"LOW"},{"id":"M9972","name":"Infarction","relevance":"LOW"},{"id":"M5483","name":"Cerebral Infarction","asFound":"Ischemic Stroke","relevance":"HIGH"},{"id":"M10046","name":"Sleep Initiation and Maintenance Disorders","asFound":"Insomnia","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"M21995","name":"Brain Infarction","relevance":"LOW"},{"id":"M5484","name":"Brain Ischemia","relevance":"LOW"},{"id":"M11974","name":"Necrosis","relevance":"LOW"},{"id":"M22344","name":"Sleep Disorders, Intrinsic","relevance":"LOW"},{"id":"M22345","name":"Dyssomnias","relevance":"LOW"},{"id":"M15386","name":"Sleep Wake Disorders","relevance":"LOW"},{"id":"M4505","name":"Mental Disorders","relevance":"LOW"},{"id":"M14163","name":"Psychotic Disorders","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"BXM","name":"Behaviors and Mental Disorders"}]}},"hasResults":false}